This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of British Columbia directory, so their publications, courses and email address may be missing. Find their university profile.
Latest funding
- $2,000,000
Allogeneic regulatory T cell therapy to prevent graft versus host disease
CIHR · 2024 · Principal investigator
- $20,000
Allogeneic regulatory T cell therapy to prevent chronic graft versus host disease
CIHR · 2023 · Principal investigator
Allogeneic regulatory T cell therapy to prevent graft versus host disease
Principal investigators: Levings, Megan K; Schultz, Kirk R; Ahmad, Imran; Dijke, Ilona E; Hay, Kevin A; Lad, Deepesh P; West, Lori J
Keywords: Cell Therapy; Graft Versus Host Disease; Regulatory T Cells; Tolerance; Transplantation
Allogeneic regulatory T cell therapy to prevent chronic graft versus host disease
Principal investigators: Levings, Megan K; Delisle, Jean-Sébastien; Ahmad, Imran; Dijke, Ilona E; Elsawy, Mahmoud E; Hay, Kevin A; Kekre, Natasha; Szwajcer, David; West, Lori J
Keywords: Cell Therapy; Graft Versus Host Disease; Regulatory T Cells; Tolerance; Transplantation
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.